Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis

Hepatobiliary and Pancreatic Diseases International

Volumn 7, Issue 2, 2008, Pages 179-184

  Wang, He Yan ^a   Cheng, Ming Liang ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Dan shao hua xian capsules; Hepatic fibrosis; NF kappa B; Peroxisome proliferator activated receptors

Indexed keywords

ALANINE AMINOTRANSFERASE; ASTRAGALUS MEMBRANACEUS EXTRACT; CHINESE DRUG; DAN SHAO HUA XIAN; GINKGO BILOBA EXTRACT; HYALURONIC ACID; HYDROXYPROLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PAEONIA RADIX; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SALVIA MILTIORRHIZA EXTRACT; TETRANDRINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MICROSCOPY; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TREATMENT DURATION; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DRUGS, CHINESE HERBAL; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; NF-KAPPA B; PHYTOTHERAPY; PPAR GAMMA; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 42149169774     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ming LC, Chang QY. The basic study and clinical research on hepatic fibrosis. Second ed. Los Angeles: First Jumbo Publishing Co.;2002:58-60.
2. Houseknecht KL, Cole BM, Steele PJ. Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review. Domest Anim Endocrinol 2002;22:1-23.
3. Takashima T, Fujiwara Y, Higuchi K, Arakawa T, Yano Y, Hasuma T, et al. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. Int J Oncol 2001;19: 465-471.
4. Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A 1997;94:237-241.
5. Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol 2006;6:111-130.
6. Yang Q, Xie RJ, Geng XX, Luo XH, Han B, Cheng ML. Effect of Danshao Huaxian capsule on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibrotic liver of rats. World J Gastroenterol 2005;11:4953-4956.
7. Li CX, Li L, Lou J, Yang WX, Lei TW, Li YH, et al. The protective effects of traditional Chinese medicine prescription, han-dan-gan-le, on CC14-induced liver fibrosis in rats. Am J Chin Med 1998;26:325-332.
8. Yang Q, Xie RJ, Luo XH, Han B, Yang T, Fang L, et al. Expression of PKC in rat hepatic fibrosis and the effect of Dan-shao-hua-xian Capsule on its expression pattern. Zhonghua Gan Zang Bing Za Zhi 2005;13:707-708.
9. Cheng ML, Yang CQ. The basic study and clinical research on hepatic fibrosis. Beijing Renmin Weisheng Chubanshe;2002:124-135.
10. Cheng ML, Zhang WS. The gene expression of connective tissue growth factor and transforming growth factor β1 in immunological induced liver fibrosis in rats and effect of HANDANGANLE on them. Guizhou Science 2003;Z1:112-115.
11. Xie RJ, Yang Q. Effects of Danshaohuaxian capsules on expression of MMP-1 in rat hepatic fibrosis. Journal of Guiyang Medical College 2004;5:21-25.
12. Cheng ML, Lu YY, Wu J, Luo TY, Ding YS. Clinical Study on Reversing Hepatic Fibrosis with Handan Ganle Capsule. Chinese J Integrated Traditional Western Med 2001;7: 16-18.
13. Ferre P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes 2004;53:S43-50.
14. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-650.
15. Tontonoz P, Hu E, Spiegelman BM. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 1995;5:571-576.
16. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275:2247-2250.
17. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem 2000;275:35715-35722.
18. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002;12:1924-1940.
19. Hazra S, Xiong S, Wang J, Rippe RA, Krishna V, Chatterjee K, et al. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 2004;279:11392-11401.
20. Calzado MA, Bacher S, Schmitz ML. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem 2007;14:367-376.
21. Anan A, Baskin-Bey ES, Bronk SF, Werneburg NW, Shah VH, Gores GJ. Proteasome inhibition induces hepatic stellate cell apoptosis. Hepatology 2006;43:335-344.
22. Uchimura K, Nakamuta M, Enjoji M, Irie T, Sugimoto R, Muta T, et al. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells. Hepatology 2001;33:91-99.
23. Kleemann R, Gervois PP, Verschuren L, Staels B, Princen HM, Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood 2003;101:545-551.
24. Delerive P, Gervois P, Fruchart JC, Staels B. Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators. J Biol Chem 2000;275:36703-36707.